Pyrotinib in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

NCT03412383 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
HER2 Gene Mutation

Interventions

DRUG: Pyrotinib

Sponsor

Peking Union Medical College